K960084 · Hi Chem, Inc. · CFR · Apr 4, 1996 · Clinical Chemistry
Device Facts
Record ID
K960084
Device Name
HICHEM GLUCOSE/HK REAGENT KIT
Applicant
Hi Chem, Inc.
Product Code
CFR · Clinical Chemistry
Decision Date
Apr 4, 1996
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 862.1345
Device Class
Class 2
Indications for Use
HiChem Glucose/HK Reagent (product no. 70007) is for the quantitative determination of glucose in serum, plasma, cerebrospinal fluid and urine. The most common causes of abnormal glucose levels are diabetes, liver disease, and certain endocrine disorders.
Device Story
In vitro diagnostic reagent kit for quantitative glucose measurement; utilizes enzymatic phosphorylation via hexokinase and ATP; glucose-6-phosphate production measured via NADH generation; manual or automated clinical analyzer use; liquid-stable components combined before/during use; provides glucose concentration values; aids clinicians in diagnosing diabetes, liver disease, and endocrine disorders.
Clinical Evidence
Bench testing only. Evaluated linearity (up to 1000 mg/dL automated), precision (n=30-60 replicates), and stability. Comparative studies performed against predicate reagents using serum, plasma, urine, and CSF samples. Regression analysis showed high correlation (r=0.997-1.000) across all matrices. Chemical additive interference (heparin, EDTA, etc.) showed bias <2 mg/dL.
Technological Characteristics
Liquid-stable enzymatic reagent kit; hexokinase/glucose-6-phosphate dehydrogenase methodology; spectrophotometric NADH detection; compatible with manual or automated clinical analyzers (e.g., Hitachi 704); no software/algorithm components; no energy source.
Indications for Use
Indicated for quantitative glucose determination in serum, plasma, cerebrospinal fluid, and urine to assist in diagnosing diabetes, liver disease, and endocrine disorders.
Regulatory Classification
Identification
A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.
Special Controls
*Classification.* Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
Predicate Devices
BMD Glucose/HK Reagent (product no. 704035)
Sigma Glucose (HK) Reagent (procedure no. 16-UV)
Submission Summary (Full Text)
{0}
K960084
# SUMMARY OF 510(K) SAFETY AND EFFECTIVENESS INFORMATION
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
HiChem Glucose/HK Reagent (product no. 70007) is for the quantitative determination of glucose in serum, plasma, cerebrospinal fluid and urine. The most common causes of abnormal glucose levels are diabetes, liver disease, and certain endocrine disorders.
The HiChem Glucose/HK Reagent determines glucose by enzymatic phosphorylation using ATP in the presence of hexokinase. The extent of this reaction, and the quantity of glucose in the specimen, is determined through the measurement of the resulting glucose-6-phosphate by producing NADH in the presence of glucose-6-phosphate dehydrogenase.
The HiChem Glucose Reagent is intended to be used either as a manual procedure or on clinical analyzers which can automate the required manipulations. The reagent is supplied as two liquid-stable components which are combined, either before or during use, in the approximate ratio of 1 part Glucose Enzyme Reagent and 8 parts Glucose Reagent Buffer. The Glucose Enzyme Reagent can also be used as a start reagent and combined with the Reagent Buffer following sample addition.
The HiChem Glucose/HK Reagent calibrated with the HiChem Chemistry Standard, product 70023 is substantially equivalent to the BMD Glucose/HK Reagent, product no. 704035 calibrated with Precise Calibrator Serum and Diluent, product no. 620213, both manufactured by Boehringer Mannheim Corp., Indianapolis, IN. and the Sigma Glucose (HK) Reagent, procedure no. 16-UV calibrated with Glucose/Urea Nitrogen Standard, product no. 16-300, both manufactured by Sigma Diagnostics, St. Louis, MO. Substantial equivalence between the HiChem and the other calibrators for the purpose of calibrating urea nitrogen methods is also shown. All three reagent/calibrator pairs support the same intended use (with the exception of the specimen limitations for the Sigma reagent) and produce equivalent results with the same clinical purpose. In addition, they are all based on the same methodology which determines glucose through the measurement of NADH production. Finally, all reagents are sold in a generic format with their use on various instruments supported through procedure supplements (application sheets).
The effectiveness of the manual procedure is shown by the recovery of linearity standards, the precision of control recoveries, a comparison of serum and plasma recoveries to the Sigma Glucose (HK) Reagent, a comparison of urine and CSF recoveries to the BMD Glucose/HK Reagent and validation of the chemical additive and reconstituted stability claims.
The recovery of glucose using HiChem Glucose/HK Reagent as a manual method is linear to at least 500 mg/dL as shown by the recovery of linearity standards which span the claimed linear range. Regression statistics are shown below.
$$( \text{HiChem Results}) = 2.1 \, \text{mg/dL} + 0.9769 \times (\text{Standard Value}) $$ r = 0.9999, $s_{y,x} = 2.6 \, \text{mg/dL} $.
Precision, demonstrated by replicate assay of commercially available control sera and urine pools, is shown below.
| Specimen | n | mean | within run SD | total SD |
| --- | --- | --- | --- | --- |
| Low serum control | 30 | 95.6 mg/dL | 0.89 mg/dL | 2.77 mg/dL |
| High serum control | 30 | 296.1 mg/dL | 2.78 mg/dL | 4.41 mg/dL |
| Low urine pool | 30 | 18.7 mg/dL | 0.75 mg/dL | 1.50 mg/dL |
| High urine pool | 30 | 274.2 mg/dL | 2.10 mg/dL | 6.95 mg/dL |
| Low CSF control | 30 | 59.8 mg/dL | 0.78 mg/dL | 2.9 mg/dL |
| High CSF control | 30 | 41.9 mg/dL | 1.11 mg/dL | 2.8 mg/dL |
Glucose recoveries of 80 mixed serum and plasma specimens are compared between the HiChem and Sigma reagents. Glucose recoveries of 36 spiked urine specimens and 37 CSF specimens are compared between the
LAN Diagnostics Division
HiChem
231 North Puente Street, Brea, California 92621
Telephone: (714) 871-8360 / (800) 422-3526 / Fax: (714) 871-2439
510(k) Notification, HiChem Glucose/HK Reagent Kit
HiChem / Elan Diagnostics Division, Brea, California
Page 80 of 81
9 January, 1996
{1}
HiChem Glucose/HK Reagent and the BMD Glucose/HK Reagent used on the Hitachi 704. All reagents were calibrated with their recommended calibrators. Least squares regression statistics are shown below.
Serum/Plasma Comparison
$$
(\text{HiChem Results}) = 0.2 \, \text{mg/dL} + 1.013 \times (\text{Sigma Results}) \quad r = 0.999, \quad s_{y.x} = 2.3 \, \text{mg/dL}.
$$
Urine Comparison
$$
(\text{HiChem Results}) = 4.1 \, \text{mg/dL} + 0.944 \times (\text{BMD Results}) \quad r = 0.998, \quad s_{y.x} = 5.58 \, \text{mg/dL}.
$$
CSF Comparison
$$
(\text{HiChem Results}) = 1.9 \, \text{mg/dL} + 0.972 \times (\text{BMD Results}) \quad r = 0.997, \quad s_{y.x} = 1.8 \, \text{mg/dL}.
$$
The use of heparin, EDTA, fluoride, oxalate and iodoacetate are shown to be acceptable chemical additives by comparison of spiked and unspiked serum pools. In all cases, the biases observed were less than $2\,\text{mg/dL}$.
The stability of the combined working reagent over 3 months at $2-8^{\circ}\text{C}$ and 10 days at $18-25^{\circ}\text{C}$ are documented through the recovery of serum controls and linearity standards which span the claimed linear range of the method. In all cases, the observed shifts in standard recovery were less than $1.8\%$.
The effectiveness of the automated Hitachi 704 procedure is shown by the recovery of linearity standards, the precision of control recoveries, comparison of patient specimen recoveries to the BMD Glucose/HK Reagent and the recovery of serum controls over the claimed calibration stability period.
The recovery of glucose using HiChem Glucose/HK Reagent as an automated method is linear to at least 1000 mg/dL as shown by the recovery of linearity standards which span the claimed linear range. Regression statistics are shown below.
$$
(\text{HiChem Results}) = 1.4 \, \text{mg/dL} + 0.986 \times (\text{Standard Value}), \quad r = 1.0000, \quad s_{y.x} = 2.7 \, \text{mg/dL}.
$$
Precision, demonstrated by replicate assay of commercially available control sera and urine pools, is shown below.
| Specimen | n | mean | within run SD | total SD |
| --- | --- | --- | --- | --- |
| Low serum control | 60 | 86.5 mg/dL | 0.68 mg/dL | 1.07 mg/dL |
| Mid. serum control | 60 | 294.0 mg/dL | 1.18 mg/dL | 2.09 mg/dL |
| High serum control | 60 | 577.5 mg/dL | 2.18 mg/dL | 5.39 mg/dL |
| Low urine pool | 60 | 23.5 mg/dL | 0.67 mg/dL | 0.77 mg/dL |
| High urine pool | 60 | 669.5 mg/dL | 2.41 mg/dL | 4.88 mg/dL |
| Low CSF control | 58 | 33.6 mg/dL | 1.02 mg/dL | 1.13 mg/dL |
| High CSF control | 59 | 57.2 mg/dL | 0.78 mg/dL | 1.26 mg/dL |
Glucose recoveries of 105 mixed serum and plasma specimens, 56 spiked urine specimens and 40 CSF specimens, compared between the HiChem and BMD reagents using least squares regression, yield the following statistics.
Serum/Plasma Comparison
$$
(\text{HiChem Results}) = -1.1 \, \text{mg/dL} + 1.004 \times (\text{BMD Results}) \quad r = 0.999, \quad s_{y.x} = 1.61 \, \text{mg/dL}.
$$
Urine Comparison
$$
(\text{HiChem Results}) = -1.4 \, \text{mg/dL} + 0.989 \times (\text{BMD Results}) \quad r = 0.999, \quad s_{y.x} = 3.3 \, \text{mg/dL}.
$$
CSF Comparison
$$
(\text{HiChem Results}) = 0.1 \, \text{mg/dL} + 0.978 \times (\text{BMD Results}) \quad r = 0.999, \quad s_{y.x} = 1.1 \, \text{mg/dL}.
$$
The calibration stability claim of one month is documented through the recovery of serum controls which span from 43 to $570\,\text{mg/dL}$ glucose. In all cases, the observed shifts in recoveries over 47 days without calibration are less than the greater of $2\,\text{mg/dL}$ or $2\%$.
The HiChem Glucose/HK Reagent, calibrated with the HiChem Chemistry Standard, is shown to be safe and effective and substantially equivalent to the Sigma Glucose (HK) Reagent, procedure no. 16-UV, calibrated with Sigma Glucose/Urea Nitrogen Standard, product no. 16-300 and the BMD Glucose/HK Reagent, product no. 857429, calibrated with Precal Calibrator Serum and Diluent, product no. 620213.

510(k) Notification, HiChem Glucose/HK Reagent Kit
HiChem / Elan Diagnostics Division, Brea, California
Page 81 of 81
9 January, 1996
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.
Copy this now. It will not be shown again.
Connected apps
Apps you authorized through browser sign-in. Disconnecting revokes their access immediately.
Learn the FDA Browser
Two short videos show you everything — or skip straight to the written tutorial if you'd rather read. You can reopen this any time from the Tutorial button in the top bar.
Part 1 — Search, results, and everyday workflows 16 min
Part 2 — Embeddings: the galaxy map 3 min
1. Search: exact and fuzzy
Type a phrase like "coronary artery calcification" into the search box. You get two kinds of results. Exact results match the literal phrase — prefix searches work ("coronary artery calcificati") but suffix searches do not. Fuzzy results match on the meaning and intent of your phrase rather than the exact words, and are sorted by relevance score. Hover over the Exact or Fuzzy badge on any row to see exactly why it matched.
Use the checkboxes above the results to narrow: SaMD keeps only software-only devices, AI / ML keeps only devices with AI.
Exact vs. fuzzy search: what's the difference?
Exact matches on the literal phrase (prefix search works, suffix does not). Fuzzy matches on the meaning and intent of the phrase rather than the exact words. Hover over the badge on any row to see why it matched.
You search "coronary artery calcification" and want only software devices with AI. What two filters do you apply?
Narrow by SaMD (software-only devices), then narrow by AI/ML (devices with AI).
2. The results table
Scroll right in the results table. The intended use is extracted for you — no need to open the PDF. The device story gives a high-level snapshot of what the device does and how it's used. The AI Performance sub-table shows each output name, acceptance criteria, observed values, and development/test dataset descriptions — the same format Innolitics uses for regulatory strategy outputs, and the fastest high-level fingerprint of an AI device. It is AI-generated but has been very reliable in practice.
Where do you find a device's intended use without opening the PDF?
Scroll right in the search results table. The intended use column is extracted for you; no need to dig into the 510(k) summary PDF.
What does the AI Performance sub-table show, and why is it useful?
Output name, acceptance criteria, observed values, development dataset description, and test dataset description. It's the same format we use for regulatory strategy output and Fast 510(k) input, and the fastest high-level fingerprint of an AI device. AI-generated but reliable in practice.
3. Judging fuzzy relevance
Fuzzy results trail off in relevance as you scroll. Use three signals to decide how far down to go: the fuzzy badge explanations, the intended use column, and whether your target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, you're past the relevant zone. A top hit with a low score (~0.4) and a stretched explanation is a hint the closest predicates are far away — the project may be headed for De Novo. Note the fuzzy search is a pattern match: it doesn't handle negation ("not") well, and hardware devices can appear — filter by SaMD/AI ML to cut them.
How do you judge how far down fuzzy search results to go?
Use the relevancy signals: the fuzzy badge explanations, the intended use column, and whether the target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, results are trailing off in relevancy.
4. Device detail page: chat and citations
Click a device name to open its detail page: device facts on the left, a chat window on the right. Ask something like "Describe the training data". The answer carries little citation bubbles — click one to jump to the highlighted passage in the source PDF, so you can verify every AI answer against the document. There's also a Download PDF button for sharing.
How do you verify an AI chat answer on the device detail page?
Click the citation bubbles to jump to the relevant highlight in the source document.
Reading rule for every project: how many summaries do you read in full?
At least the three most relevant 510(k) or De Novo summaries, in full. After that, use targeted chat questions to confirm your memory quickly. The tool supports this professional habit — it doesn't replace it.
5. Side-by-side comparison
Select multiple rows in the results table (aim for under ~10), then open the PDF Viewer tab. Ask one question — it goes to all selected devices in parallel, each with citations. This is the fastest way to compare and contrast devices: training data, PCCP scope, how they handled adding new scanners, and so on.
What does the side-by-side PDF viewer mode do?
Select multiple devices, open the PDF viewer tab, and ask one question (e.g., "Describe the training data"). It queries all selected devices simultaneously with citations, so you can compare and contrast quickly.
6. Collections
With rows selected, go to the Collections tab and create a labeled collection (e.g., "Cobb Angle Project"). Reload that selection any time — before a client call, pull up the collection and ask questions across all of its devices at once.
How do you save a set of selected devices for later use?
Select the rows, go to the Collections tab, and create a labeled collection (e.g., "Cobb Angle Project"). You can reload the selection anytime and carry it into the PDF viewer and other tabs that support selections.
7. Product codes and the regulations tree
Click a product code in the results to jump to it in the regulations tree — identification text, sibling product codes, and devices you can open in a PDF viewer on the right. Click a regulation number to see its identification, special controls, and related product codes. You can also search by product code or regulation number at the top of the tree. Always read the special controls if any exist for your device — it broadens your search and sharpens pre-kickoff research.
What can you do from the regulations tree view?
Browse product codes and regulation numbers, read the identification text and special controls, browse sibling product codes, open device PDFs on the right, and search by product code or regulation number at the top of the tree.
8. Chart view
Click Show Chart and segment by regulation number (or product code) to see which regulations dominate your result set. Clicking a regulation takes you into the regulations tree. Great for spotting that most matches are, say, hardware laparoscopic devices — a cue to go back and filter.
How do you see which regulations dominate a search result set?
Click "Show Chart" and segment by Regulation Number. Clicking a regulation takes you to the regulations tree.
9. The predicate graph
Open the Predicates tab for a family-tree view of predicate relationships. Click a node to trace its parents and children; selections from search carry over pre-selected. Commonly predicated devices are worth reading — a lot of people predicated them for a reason. The visual lineage is also handy on client calls, e.g. to show how a predicate family evolved and justify why your predicate still holds.
In the predicate graph, why are commonly predicated devices worth reading?
A lot of people predicated them for a reason. Clicking a node traces parents and children, and selections from search carry over pre-selected.
10. Embeddings: the galaxy map
The Embeddings tab plots every matching document in a 2-D "galaxy map" where semantically similar devices cluster together. Hover or click clusters to explore, and let AI label the clusters for you. Embeddings beat product codes for grouping: two devices can carry different product codes (LLZ vs. QIH) yet do the same thing — the embedding captures the meaning of the intended use and device story. This is also exactly how retrieval-augmented generation (RAG) works under the hood, and it makes a great visual on client calls.
Try it yourself
Head to the search page and work through a few of these AI/ML fuzzy searches to build intuition: perivascular fat on CT · aortic valve calcification opportunistic screening on noncontrast CT · breast cancer prediction on digital pathology slides · autism detection · gestational age prediction · a hearing aid that can also detect a pulse · foundation model based analysis of ECG · large language models · penetration test. Watch how the relevance scores, intended use, and AI Performance tables tell you when results stop being meaningful.